NCT01434602 2022-06-01Phase I-II Everolimus and Sorafenib in Recurrent High-Grade GliomasNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed86 enrolled 24 charts
NCT00335764 2018-07-02Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or GliosarcomaNational Cancer Institute (NCI)Phase 1/2 Completed92 enrolled 24 charts